Novel candidates are associated with neurodegenerative disorders including Alzheimer's disease (VSNL1), prion disease (SCRG1, HSPH1, HSPA5 (Figure 4B) and CTR9) and age-related degeneration (GAS6 and GNG11). Here, HSPA5 is linked to Alzheimer disease.